Decision making/Best interests

Case and Commentary
Jan 2005

Mr. Douglas's Choice of Treatment, Option Comparison
Jeanne Sokolec, EdD, MSW

Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5b-0501.
Case and Commentary
Jan 2005

Mr. Harvey's Central Line, Option Assessment
Jennifer Reenan, MD

Virtual Mentor. 2005;7(1):61-67. doi: 10.1001/virtualmentor.2005.7.1.ccas11a-0501.
Case and Commentary
Jan 2005

Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment
Jeanne Sokolec, EdD, MSW

Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501.
Case and Commentary
Jan 2005

Mrs. Douglas's Choice of Treatment for Her, Option Comparison
Jennifer Reenan, MD

Virtual Mentor. 2005;-. doi: 10.1001/virtualmentor.2005.7.1.ccas7b-0501.
Case and Commentary
Jan 2005

Mr. Douglas's Choice of Treatment, Additional Information
Jeanne Sokolec, EdD, MSW

Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5c-0501.
Case and Commentary
Jan 2005

Mr. Harvey's Central Line, Option Comparison
Jennifer Reenan, MD

Virtual Mentor. 2005;7(1):61-67. doi: 10.1001/virtualmentor.2005.7.1.ccas11b-0501.
Case and Commentary
Nov 2004

Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2
Karen Kreiner, MD
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.
Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary
Nov 2004

Clinical Trials and End-of-Life Decision Making, Commentary 2
Lucy Godley, MD, PhD
Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care.
Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary
Nov 2004

Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1
Charles Weijer, MD, PhD
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.
Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary
Nov 2004

Clinical Trials and End-of-Life Decision Making, Commentary 1
David S. Alberts, MD
Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care.
Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.